NYSE · WST
WEST PHARMACEUTICAL SERVICES INC (WST) Valuation & Financials
WEST PHARMACEUTICAL SERVICES INC (WST) is listed on NYSE. Its market capitalization is about $24.4B. On trailing-twelve-month earnings the P/E ratio is 43.21, and the P/B ratio is 8.16. Return on equity is 18.9%. These figures are computed in-house from official filings and are reference information only.
Valuation & financial metrics
- Market cap
- $24.4B
- P/E
- 43.21
- P/B
- 8.16
- P/S
- 7.34
- EPS
- $8.07
- ROE
- 18.9%
- Dividend yield
- 0.25%
Basis: Trailing twelve months · consolidated · controlling interest · 최근 4개 분기(TTM)
See the full analysis in Korean (AI committee, filings, earnings)Questions & answers
What is the P/E ratio of WEST PHARMACEUTICAL SERVICES INC (WST)?
On a trailing-twelve-month basis, WST trades at a P/E ratio of 43.21. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
What is the market capitalization of WEST PHARMACEUTICAL SERVICES INC?
WST has a market capitalization of about $24.4B. The figure moves with the share price and is refreshed each trading day.
Does WEST PHARMACEUTICAL SERVICES INC pay a dividend?
WST has a dividend yield of about 0.25%, based on disclosed payment history. Dividend policy can change; this is reference information only.
Is this page investment advice?
No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, a price forecast, or a buy or sell recommendation. Investment decisions rest with the user.
All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.